A Study to Test Whether Spesolimab Helps People With Crohn's Disease Who Have Symptoms of Bowel Obstruction

PHASE2TerminatedINTERVENTIONAL
Enrollment

5

Participants

Timeline

Start Date

November 9, 2021

Primary Completion Date

May 31, 2022

Study Completion Date

May 31, 2022

Conditions
Fibrostenotic Crohn´s Disease
Interventions
DRUG

Spesolimab

Spesolimab

DRUG

Placebo

Placebo

Trial Locations (4)

63110

Washington University School of Medicine, St Louis

T2N 4Z6

Heritage Medical Research Clinic, Calgary

108-8642

Kitasato Institute Hospital, Tokyo, Minato-ku

431 80

Sahlgrenska Universitetssjukhuset, Mölndal, Mölndal

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY